Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.
暂无分享,去创建一个
E. Boscolo | J. Mulliken | J. Melero-Martin | J. Bischoff | Z. Khan | Arnaud Picard | Tatianna C Bartch | Sarah Psutka
[1] Song Yu,et al. A Novel In Vivo Model of Human Hemangioma: Xenograft of Human Hemangioma Tissue on Nude Mice , 2007, Plastic and reconstructive surgery.
[2] Joyce Bischoff,et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. , 2007, Blood.
[3] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[4] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[5] C. Marras,et al. Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype , 2006, Glia.
[6] E. Boscolo,et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. , 2006, Blood.
[7] J. Mulliken,et al. Mesenchymal Stem Cells and Adipogenesis in Hemangioma Involution , 2006, Stem cells.
[8] M. Friedlander,et al. Myeloid cells in infantile hemangioma. , 2006, The American journal of pathology.
[9] P. Steijlen,et al. The Pathogenesis of Hemangiomas: A Review , 2006, Plastic and reconstructive surgery.
[10] Gabriel S. Eichler,et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Maitland,et al. Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.
[12] F. Schweizer,et al. Neuronal Differentiation of Bone Marrow-derived Stromal Stem Cells Involves Suppression of Discordant Phenotypes through Gene Silencing* , 2005, Journal of Biological Chemistry.
[13] S. Rafii,et al. AC133/CD133/Prominin-1. , 2005, The international journal of biochemistry & cell biology.
[14] L. Olson,et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. , 2004, Carcinogenesis.
[15] L. Lagneaux,et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. , 2004, Differentiation; research in biological diversity.
[16] K. Preissner,et al. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood , 2004, Thrombosis and Haemostasis.
[17] Joyce Bischoff,et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. , 2004, American journal of physiology. Heart and circulatory physiology.
[18] D. Neal,et al. CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.
[19] J. Mulliken,et al. Endothelial progenitor cells in infantile hemangioma. , 2004, Blood.
[20] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[21] N. Callander,et al. AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma , 2003 .
[22] Y. Tabata,et al. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. , 2002, Tissue engineering.
[23] J. Bischoff. Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences? , 2002, Trends in cardiovascular medicine.
[24] C. Verfaillie,et al. Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.
[25] M. Mihm,et al. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. , 2001, Archives of dermatology.
[26] M. Mihm,et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. , 2001, Archives of dermatology.
[27] J. Mulliken,et al. Clonality and altered behavior of endothelial cells from hemangiomas. , 2001, The Journal of clinical investigation.
[28] J. Reinisch,et al. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells , 2000, Journal of cutaneous pathology.
[29] Y. Ikada,et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. , 2000, Tissue engineering.
[30] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[31] C. Bucana,et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. , 1999, International journal of oncology.
[32] M. Kennedy,et al. A common precursor for hematopoietic and endothelial cells. , 1998, Development.
[33] E. Nicodemou-Lena,et al. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Wassef,et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. , 1997, The American journal of pathology.
[35] Y. Iwamoto,et al. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo , 1996, International journal of cancer.
[36] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[37] B. Smoller,et al. Infantile (juvenile) capillary hemangioma: A tumor of heterogeneous cellular elements , 1993, Journal of cutaneous pathology.
[38] A. Greenberg,et al. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. , 1991, The Journal of biological chemistry.
[39] D. Mason,et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.
[40] R. Auerbach,et al. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[41] D. Hanahan,et al. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene , 1987, Cell.
[42] L. Cotton. Vascular malformations (Angiodysplasias). Edited E. Malan, Milan. 240 × 170 mm. Pp. 213, with 176 illustrations. 1974. Milan: Carlo Erba Foundation. No price given , 1975 .
[43] Catherine M. Verfaillie,et al. Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.
[44] N. Speck,et al. Runx1 function in hematopoiesis is required in cells that express Tek. , 2006, Blood.
[45] E. Christison-Lagay,et al. Vascular anomalies. , 2006, The Surgical clinics of North America.
[46] D. Senger,et al. In vivo and in vitro models of Mammalian angiogenesis. , 2005, Methods in molecular biology.
[47] N. Callander,et al. AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma. , 2003, Blood.
[48] M. Mihm,et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. , 2000, Human pathology.
[49] R. Virchow,et al. Die krankhaften Geschwülste , 1978 .
[50] G. Pack,et al. Hemangiomas; classification, diagnosis and treatment. , 1950, Angiology.
[51] R. Virchow. Die krankhaften Geschwülste : dreissig Vorlesungen, gehalten während des Wintersemesters 1862-1863 an der Universität zu Berlin , 1863 .